glp 1 tirzepatide mounjaro for Weight Loss FDA approval for Zepbound (tirzepatide)
Description
Schneberg, T
Glucagon-like peptide-1 receptor agonists are already widely used for obesity and diabetes, including increasing self-administration by patients outside medical supervision
P.MillerC
Ooh, that's that's a mouthful, is it not
In addition, the discrimination of traditional predictors including baseline HbA1c and C-peptide concentrations were also evaluated (AUROC were 0.71 and 0.66, respectively)
10.1002/path.5056 J
